Our results from the present study emphasize the importance of the presence of high levels of circulating pDCs, low levels of immunosuppressive cells and the presence of CD8+ T-cell responses to Her-2 in predicting a favorable outcome in breast cancer patients both for all patients, and when only non-metastatic patients were considered. Here, CD8A is linked to breast cancer.